DECN Remarks on The latest Lawful Filings by Federal Companies

LOS ANGELES, CA / ACCESSWIRE / December 18, 2020 / Determination Diagnostics Corp. (OTC:DECN) www.decisiondiagnostics.co, a major manufacturer and around the world distributor of diabetic examination strips engineered to run on legacy glucose meters by way of its subsidiary Pharma Tech Methods, Inc., as effectively as the designer and maker of the GenViro! Covid-19 Swift Kit testing kits, hereby confirms two the latest authorized filings by different organizations of the Federal govt pertaining to DECN and its CEO Keith Berman about its GenViro! Covid-19 tests products and solutions.

Keith Berman, the CEO of DECN, was charged yesterday in Los Angeles by the United States Office of Justice with 1 rely of securities fraud and 1 depend of generating a wrong statement to govt officers. It is alleged that Mr. Berman designed wrong and deceptive statements in relationship with DECN’s work to develop, check and attain regulatory approvals for a COVID-19 examination kit. No charges had been brought towards DECN.

In accordance with the conditions of his arrangement with this federal government company, Mr. Berman will go on to carry on with his operate at DECN, where in addition to handling the affairs of the business, and handling the company’s GenUltimate! diabetes tests product line, his overarching emphasis is to oversee the completion of, as nicely as efforts to safe domestic and worldwide regulatory approvals, and thereafter the advertising and marketing of the firm’s COVID-19 line of check kits.

Significantly comparable civil expenses were being submitted yesterday afternoon versus Mr. Berman and DECN by the United States Securities and Exchange Fee in New York Federal Court docket. Both equally filings consist entirely of allegations. Mr. Berman, who intends to vigorously obstacle all charges from him and DECN, is presumed by legislation to be innocent.

Get hold of Facts:
Decision Diagnostics Corp.
[email protected]
www.genultimate.com
www.genultimatetbg.com
www.pharmatechdirect.com

Extra Speak to Information:
Decision Diagnostics Corp.
Shep Doniger 561-637-5750
[email protected]

Source: Final decision Diagnostics Corp.

Check out source model on accesswire.com:
https://www.accesswire.com/621636/DECN-Comments-on-Latest-Lawful-Filings-by-Federal-Organizations